Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Indications & Uses
This Diphtheria, Tetanus, Pertussis, Poliomyelitis Vaccine is used to prevent diphtheria, tetanus, pertussis and poliomyelitis. It is given as primary vaccination to infants from the age of 2 months. It is also given as a booster one year after primary vaccination, during the second year of life, and as another booster between 5 and 13 years of age. All of this follows official recommendations.
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
The Diphtheria, Tetanus, Pertussis, Poliomyelitis Vaccine must be administered according to the official recommendations in effect. For primary vaccination, give 3 injections one month apart. On the official schedule, that means at the age of 2, 3 and 4 months. The booster is 1 injection one year after primary vaccination, which is usually between 16 and 18 months. A booster between 5 and 13 years of age is also 1 injection.
For primary vaccination and for the first booster dose, this vaccine may be administered by reconstituting the Haemophilus influenzae type b conjugate vaccine (Act-HIB). It may also be administered at the same time as that vaccine, but at two separate injection sites.
Administer it by the intramuscular route. The preferred site is the antero-lateral side of the thigh (middle third) in infants, and the deltoid area in children.
Side Effects
The safety information below comes from clinical data gathered in France, South Korea, Chile and Thailand. In studies of children who received TETRAXIM as a primary series, either on its own or together with the Act-HIB vaccine, the reactions reported most often were local reactions at the injection site, abnormal crying, loss of appetite and irritability. These signs and symptoms usually start within 48 hours of the vaccination and may last for 48 to 72 hours. They go away on their own and need no specific treatment. Injection-site reactions tend to be more frequent after a booster dose than after the primary series. The safety profile of TETRAXIM does not differ significantly between age groups. However, some reactions (myalgia, malaise and headache) are seen only in children aged 2 years or more.
Cautions & Contraindications
Warnings & Precautions
The Diphtheria, Tetanus, Pertussis, Poliomyelitis Vaccine may work less well in people on immunosuppressive treatment or those with immunodeficiency. In that case, it's recommended to wait until the treatment or the disease has ended before vaccinating. Even so, people with chronic immunodeficiency, such as HIV infection, should still be vaccinated, though the immune response may be limited. If Guillain-Barre syndrome or brachial neuritis has occurred after an earlier vaccine containing tetanus toxoid, the decision to give any vaccine with tetanus toxoid should rest on a careful look at the possible benefits and the possible risks of vaccination. Vaccination is usually justified for infants whose primary immunization schedule is incomplete (that is, fewer than three doses given). Do not inject this vaccine into a blood vessel, so make sure the needle does not enter one. Do not inject it into the skin (intradermal route). As with all injectable vaccines, give it with caution to people with thrombocytopenia or a bleeding disorder, because bleeding may occur after an intramuscular injection in these people.
Contraindications
Diphtheria, Tetanus, Pertussis, Poliomyelitis Vaccine must not be given to anyone with hypersensitivity to any of its active substances or to any of the excipients listed in section 6.1. The same applies to hypersensitivity to glutaraldehyde, neomycin, streptomycin or polymyxin B (these are used during the manufacturing process and may be present as traces), and to hypersensitivity to a pertussis vaccine, whether acellular or whole cell. A life-threatening reaction after a previous dose of the same vaccine, or of a vaccine containing the same substances, is also a contraindication. Vaccination must be postponed if the person has a febrile or acute disease. It must not be given in evolving encephalopathy, or if encephalopathy occurred within 7 days of a previous dose of any vaccine containing pertussis antigens (whole cell or acellular pertussis vaccines).
Storage
Keep the Diphtheria, Tetanus, Pertussis, Poliomyelitis Vaccine out of the sight and reach of children. Store it at +2°C to +8°C, and keep it at the same +2°C to +8°C during transportation. Don't freeze it, and discard the solution if it has been frozen. Protect it from light.
Common questions about Tetraxim 0.5 ml
What is Tetraxim 0.5 ml SC Injection?
Tetraxim 0.5 ml SC Injection is a medicine that contains Diphtheria, Tetanus, Pertussis, Poliomyelitis Vaccine. It is made by Synovia Pharma PLC. It belongs to the Vaccines group of medicines.
What is Tetraxim used for?
This Diphtheria, Tetanus, Pertussis, Poliomyelitis Vaccine is used to prevent diphtheria, tetanus, pertussis and poliomyelitis. It is given as primary vaccination to infants from the age of 2 months.
What are the side effects of Tetraxim?
The safety information below comes from clinical data gathered in France, South Korea, Chile and Thailand. In studies of children who received TETRAXIM as a primary series, either on its own or together with the Act-HIB vaccine, the reactions reported most often were local reactions at the injection site, abnormal crying, loss of appetite and irritability.
How should I store Tetraxim?
Keep the Diphtheria, Tetanus, Pertussis, Poliomyelitis Vaccine out of the sight and reach of children. Store it at +2°C to +8°C, and keep it at the same +2°C to +8°C during transportation.
Do I need a prescription for Tetraxim?
Tetraxim is a prescription (Rx) medicine. Take it as your doctor advises.